| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.LEUKRES.2010.03.011 |
| P698 | PubMed publication ID | 20359747 |
| P2093 | author name string | Andrea G S Buggins | |
| Chris J Pepper | |||
| P2860 | cites work | TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer | Q37154117 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphocyte | Q715347 |
| leukemia | Q29496 | ||
| P304 | page(s) | 837-842 | |
| P577 | publication date | 2010-03-31 | |
| P1433 | published in | Leukemia Research | Q15716445 |
| P1476 | title | The role of Bcl-2 family proteins in chronic lymphocytic leukaemia | |
| P478 | volume | 34 |
| Q38457498 | A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine |
| Q39077324 | A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma. |
| Q42061450 | Anti-cancer drug discovery and development: Bcl-2 family small molecule inhibitors |
| Q35088734 | Apoptotic cell signaling in cancer progression and therapy |
| Q36984500 | BCL-2 inhibitors sensitize therapy-resistant chronic lymphocytic leukemia cells to VSV oncolysis |
| Q36483749 | Broad targeting of resistance to apoptosis in cancer. |
| Q38819260 | Caspase-mediated cleavage of Beclin1 inhibits autophagy and promotes apoptosis induced by S1 in human ovarian cancer SKOV3 cells. |
| Q53664065 | Collateral sensitivity to cold stress and differential BCL-2 family expression in new daunomycin-resistant lymphoblastoid cell lines. |
| Q28584308 | Cyclosporin A induces apoptosis in H9c2 cardiomyoblast cells through calcium-sensing receptor-mediated activation of the ERK MAPK and p38 MAPK pathways |
| Q39572142 | Differential cytopathology and kinetics of measles oncolysis in two primary B-cell malignancies provides mechanistic insights |
| Q39065374 | Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199). |
| Q92285247 | Effect of nucleolin on adriamycin resistance via the regulation of B-cell lymphoma 2 expression in Burkitt's lymphoma cells |
| Q34292891 | Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma |
| Q50929308 | In vivo and ex vivo responses of CLL cells to purine analogs combined with alkylating agent. |
| Q39663702 | Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF-κB Activation andDe novoGene Transcription |
| Q26781895 | Know the enemy as well as the weapons in hand: the aberrant death pathways and therapeutic agents in chronic lymphocytic leukemia |
| Q35087432 | Liposome-coated lipoplex-based carrier for antisense oligonucleotides |
| Q97530344 | MKL-1 is a coactivator for STAT5b, the regulator of Treg cell development and function |
| Q38413580 | Mechanisms of ibrutinib resistance in chronic lymphocytic leukaemia and non-Hodgkin lymphoma |
| Q86483631 | Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis |
| Q42912126 | Negative regulation of immunoreceptor signaling by protein adapters: Shc proteins join the club |
| Q35919739 | Neutrophil elastase and its therapeutic effect on leukemia cells |
| Q91173721 | New diphenylphosphane derivatives of ketoconazole are promising antifungal agents |
| Q30300125 | Nucleophosmin overexpression is associated with poor survival in astrocytoma |
| Q47695857 | Overexpressed BAG3 is a potential therapeutic target in chronic lymphocytic leukemia |
| Q55280895 | Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemia. |
| Q37978967 | Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia |
| Q38754284 | Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies |
| Q59791887 | Role and Regulation of Pro-survival BCL-2 Proteins in Multiple Myeloma |
| Q37865381 | Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. |
| Q35483640 | SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target |
| Q34193833 | Selective TRAIL-triggered apoptosis due to overexpression of TRAIL death receptor 5 (DR5) in P-glycoprotein-bearing multidrug resistant CEM/VBL1000 human leukemia cells |
| Q34173253 | Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway |
| Q90383179 | The Incomplete Puzzle of the BCL2 Proteins |
| Q36162564 | The STAT5b Pathway Defect and Autoimmunity |
| Q38237264 | The pleiotropic flavonoid quercetin: from its metabolism to the inhibition of protein kinases in chronic lymphocytic leukemia |
| Q54584717 | Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2. |
| Q38063170 | What do we do with chronic lymphocytic leukemia with 17p deletion? |
| Q49436424 | ZGDHu-1 for cancer therapy |
Search more.